Maricich Yuri 4

What Happened

• Yuri Maricich, Chief Medical Officer of Camp4 Therapeutics (CAMP), was granted a derivative award for 215,000 shares on April 1, 2026. The filing shows an acquisition at $0.00 per share (derivative), so no immediate cash purchase or sale value is reported.
• This transaction is an award/grant (transaction code A) rather than an open-market buy or sale.

Key Details

• Transaction date: 2026-04-01; Form 4 filed: 2026-04-03 (Accession 0001881045-26-000002).
• Transaction type/code: Award/Grant (A); Price reported: $0.00 per share (derivative).
• Shares involved: 215,000 (derivative award). No total dollar value reported in the filing.
• Shares owned after transaction: not disclosed in this filing.
• Footnote: The shares underlying the option/award vest in equal monthly installments over four years commencing from the date of grant.
• No indication in the filing that this was a late report.

Context

• This is a typical equity-compensation grant for an executive — a derivative award that vests over time. It is not an open-market purchase or a sale and does not necessarily indicate immediate buying/selling sentiment.